Group One Trading
ARRY

Group One Trading’s Array Biopharma Inc ARRY Stock Holding History

Group One Trading’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-172,370
Closed -$1.6M – 5395
2017
Q2 		$1.44M Sell
172,370
-73,193
-30% -$599K 0.02% 1184
2017
Q1 		$2.19M Buy
+245,563
New +$2.61M 0.03% 808
2016
Q4 		– Sell
-15,810
Closed -$116K – 5065
2016
Q3 		$107K Sell
15,810
-88,578
-85% -$343K ﹤0.01% 2890
2016
Q2 		$372K Buy
+104,388
New +$340K ﹤0.01% 1944
2016
Q1 		– Sell
-106,714
Closed -$320K – 5209
2015
Q4 		$450K Buy
+106,714
New +$487K 0.01% 1900
2014
Q4 		– Sell
-268,332
Closed -$1.06M – 5492
2014
Q3 		$958K Sell
268,332
-101,952
-28% -$402K 0.01% 1137
2014
Q2 		$1.69M Buy
370,284
+62,707
+20% +$259K 0.03% 806
2014
Q1 		$1.45M Buy
307,577
+70,756
+30% +$356K 0.02% 833
2013
Q4 		$1.19M Buy
236,821
+198,750
+522% +$1.08M 0.02% 988
2013
Q3 		$237K Buy
38,071
+16,723
+78% +$99.3K ﹤0.01% 2242
2013
Q2 		$97K Buy
+21,348
New +$115K ﹤0.01% 2842

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return

Group One Trading's ARRY Position: Q3 2017 in Review

Group One Trading sold out of Array Biopharma Inc (ARRY) in Q3 2017, closing a stake of 172,370 shares — an estimated $1.6M sold.

Group One Trading first reported a position in ARRY in Q2 2013 and held it in 11 quarters. The position peaked at $2.19M in Q1 2017. 184 funds tracked by Wall St. Rank hold ARRY as of Q3 2017.

  • Group One Trading reported no remaining Array Biopharma Inc position as of Q3 2017 after selling out during the quarter.
  • Group One Trading sold 172,370 Array Biopharma Inc shares in Q3 2017, an estimated $1.6M.
  • Group One Trading first reported a position in Array Biopharma Inc in Q2 2013 and held it in 11 quarters.
  • Group One Trading's Array Biopharma Inc position peaked at $2.19M in Q1 2017.
  • 184 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2017.

Based on Group One Trading's 13F filing for Q3 2017, filed 15 Nov 2017.